Neratinib
PUMA-NER-6201
Phase 2 small_molecule completed
Quick answer
Neratinib for Early Stage HER2+ Breast Cancer is a Phase 2 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PUMA BIOTECHNOLOGY, INC.
- Indication
- Early Stage HER2+ Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed